Navidea Biopharmaceuticals Inc (OP: NAVB )

0.0010 +0.0005 (+100.00%)
Streaming Delayed Price Updated: 10:36 AM EST, Nov 8, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
May 02, 2012
Form 8-K
Source: SEC/Edgar
April 22, 2012
Form CT ORDER
Source: SEC/Edgar
April 12, 2012
Form 8-K
Source: SEC/Edgar
April 12, 2012
Form 8-K/A
Source: SEC/Edgar
April 10, 2012
Form 8-K
Source: SEC/Edgar
April 02, 2012
Form 8-K
Source: SEC/Edgar
February 29, 2012
Form 8-K
Source: SEC/Edgar
February 15, 2012
Form 8-K
Source: SEC/Edgar
January 31, 2012
Form 8-K
Source: SEC/Edgar
January 24, 2012
Form 8-K
Source: SEC/Edgar
January 04, 2012
Form 8-K
Source: SEC/Edgar
December 29, 2011
Form 8-K
Source: SEC/Edgar
December 21, 2011
Form 8-K
Source: SEC/Edgar
December 20, 2011
Form 8-K
Source: SEC/Edgar
December 14, 2011
Form 8-K
Source: SEC/Edgar
December 07, 2011
Form 8-K
Source: SEC/Edgar
October 26, 2011
Form 8-K
Source: SEC/Edgar
October 19, 2011
Form 8-K
Source: SEC/Edgar
September 18, 2011
Form 8-K
Source: SEC/Edgar
September 08, 2011
Form 8-K
Source: SEC/Edgar
August 25, 2011
Form 8-K
Source: SEC/Edgar
August 23, 2011
Form 8-K
Source: SEC/Edgar
August 21, 2011
Form 8-K
Source: SEC/Edgar
August 16, 2011
Form 8-K/A
Source: SEC/Edgar
August 16, 2011
Form 8-K
Source: SEC/Edgar
August 09, 2011
Form 8-K
Source: SEC/Edgar
August 03, 2011
Form DEFA14A
Source: SEC/Edgar
August 01, 2011
Form 8-K
Source: SEC/Edgar
July 26, 2011
Form CT ORDER
Source: SEC/Edgar
July 19, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.